RenovaCare Appoints Alan L. Rubino as President and CEO

    NEXT STORY
    Air Methods to Refund Medicare Patients as Part of ‘No Membership Required’ Program
    PREV STORY
    Seelos Therapeutics Receives FDA Fast Track Designation for Intranasal Racemic Ketamine (SLS-002)
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Roche and Spark Therapeutics, Inc. announce extension of tender offer for shares of Spark Therapeutics, Inc.

    author_avatar
    NASDAQ Market News

    Tempus Announces (TIME) Trial Service, a New Integrated Molecular Evaluation that Leverages Artificial Intelligence to Rapidly Match Cancer Patients to Clinical Trials

    author_avatar
    NASDAQ Market News

    Cytori to Webcast Third Quarter Financial Results on November 14

    SAN DIEGO, Nov. 09, 2018 (GLOBE NEWSWIRE) -- Cytori Therapeutics, Inc. (NASDAQ: CYTX) will ...

    author_avatar
    NASDAQ Market News